In addition, the Group's subsidiary Viva Biotech Shanghai was successfully restructured into a joint stock limited company on September 27, 2024, as the Group currently holds approximately 72.9% of ...

Zhejiang Langhua Pharmaceutical Co., Ltd. ('Langhua Pharmaceutical'), a wholly-owned subsidiary of Viva Biotech Holdings ('Viva Biotech'), underwent a cGMP (Current Good Manufacturing Practices) ...

Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of ... at a third-party manufacturer of the drug. The earlier application was filed on the ...

GE HealthCare is also using ACC 2025 to highlight new AI-powered innovations for cardiac care: The latest version of CASE (Cardiac Assessment System for Stress Testing), powered by the company’s ...

The company’s AtomNet platform incorporates deep learning for structure-based drug design, enabling the rapid, AI-powered search of its proprietary library of more than three trillion synthesizable ...

Drug developers can now leverage large language models to draft regulatory documents, which they hope will shorten the time ...

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.

A senior at the Agnes Irwin School, Naomi Kim is Head of Honor Council, and was nominated by her peers at the end of her ...

The houses of two of Sweden’s most influential artists and designers, Carl and Karin Larsson, came to shape the country’s national identity — and now represent an aesthetic ideal. By Nancy ...

The first clinical trial of an AI therapist showed significant improvements for people living with depression and anxiety to the same level as a human expert.

Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...